Aravind Parameswaran Email & Phone Number

Zürich, Zh, Ch

Zurich, Switzerland

Boston, Massachusetts, Us

Boston, Massachusetts, Us

I have laterally expanded into a broader multifaceted role: Continuing as a Medical Writer leading a diverse portfolio of medical writing activities across diverse indications, and specializing in Transparency and Disclosure needs (Health Canada PRCI; EMA Policy 0070, 043, EU CTR including Plain Language Summaries)

Boston, Massachusetts, Us

Broader portfolio of writing and managing various types of regulatory documents from program initiation until follow-up post submission. In this role, I am independently leading programs, managing vendors, contract writers and developing processes. This role involves extensive management capabilities, process specialist, driving meetings and solicitng decisions from peers and subject matter experts.

Basel, Ch

Within the role of a Senior Medical Writer, I have continued to gain further experience in preparing documents catering to unqiue supplemental NDAs, pediatric submissions and Repeat Use (Mutual Recognition Procedure) submissions. In return, I have contributed to the development of standards and processes within the company, while enhancing my overall project management skills, interpersonal and negotiation skills

Basel, Ch

As a Medical Writer in the department of Drug Regulatory Affairs, I have gained significant experience working across several projects some of which culminated in unique achievements (a recent compliance to a PDCO/EMA Paediatric Investigational Plan) and regulatory approvals (OPSUMIT [macitentan]). Further, I have contributed to the preparation of different types of documents including Briefing Books, responses to Health Authority questions, Labels, Investigator's Brochure etc., Moreover, Actelion provided me a huge platform to work across diverse and rare indications (e.g.: seasonal allergic rhinitis, asthma, insomnia, idiopathic pulmonary fibrosis, Type I Gaucher disease) involving unique study designs, assessments and statistical analyses.

Ingelheim Am Rhein, Rhineland-Palatinate, De

As one of the dedicated medical writers for the therapeutic area of cardiovascular andmetabolism, my profile was enriched by 2 pivotal Phase III CSRs for 2 NDA submissions, one for TWYNSTA (Telmisartan+amlodipine combination) and the other for TRAJENTA (linagliptin). In addition, diverse Phase I CSRs in indications COPD, asthma and neurological disorders further strengthened my medical writing profile.

Basel, Baselstadt, Ch

The first step into the pharmaceutical industry at Novartis provided me an extensive experience across diverse communication materials such as publications, posters, abstracts, slide sets for brand training and newsletters for DIOVAN (Valsartan), EXFORGE (Valsartan+amlodidpine),and RASILEZ (Aliskiren). The multifaceted role of being a local publication lead for GALVUS (linagliptin), in India, involved liaison with global teams and experts (publication managers, medical/scientific expertsand marketing) to ensure implementation of the global publication strategy across assigned writers and provide ‘brand knowledge’ training.

Postdoctoral Reseracher, Protein Biochemistry

Ph D, Metalloenzymology And Biochemistry

Masters, Biology